Global Alzheimer's Disease Drug Sales Market Report 2016

November 2016 | 104 pages | ID: G33C5A40FEFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Alzheimer's Disease Drug

Revenue, means the sales value of Alzheimer's Disease Drug

This report studies sales (consumption) of Alzheimer's Disease Drug in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Eisai
• Pfizer
• Novartis
• Shire
• Janssen
• Forest Laboratories
• H. Lundbeck
• Merz
• Daiichi Sankyo

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Alzheimer's Disease Drug in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Centrally acting AChE inhibintors
• NMDA antagonists
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Alzheimer's Disease Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Alzheimer's Disease Drug Sales Market Report 2016

1 ALZHEIMER'S DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Alzheimer's Disease Drug
1.2 Classification of Alzheimer's Disease Drug
  1.2.1 Centrally acting AChE inhibintors
  1.2.2 NMDA antagonists
  1.2.3 Type III
1.3 Application of Alzheimer's Disease Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Alzheimer's Disease Drug Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Alzheimer's Disease Drug (2011-2021)
  1.5.1 Global Alzheimer's Disease Drug Sales and Growth Rate (2011-2021)
  1.5.2 Global Alzheimer's Disease Drug Revenue and Growth Rate (2011-2021)

2 GLOBAL ALZHEIMER'S DISEASE DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Alzheimer's Disease Drug Market Competition by Manufacturers
  2.1.1 Global Alzheimer's Disease Drug Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Alzheimer's Disease Drug Revenue and Share by Manufacturers (2011-2016)
2.2 Global Alzheimer's Disease Drug (Volume and Value) by Type
  2.2.1 Global Alzheimer's Disease Drug Sales and Market Share by Type (2011-2016)
  2.2.2 Global Alzheimer's Disease Drug Revenue and Market Share by Type (2011-2016)
2.3 Global Alzheimer's Disease Drug (Volume and Value) by Regions
  2.3.1 Global Alzheimer's Disease Drug Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Alzheimer's Disease Drug Revenue and Market Share by Regions (2011-2016)
2.4 Global Alzheimer's Disease Drug (Volume) by Application

3 UNITED STATES ALZHEIMER'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Alzheimer's Disease Drug Sales and Value (2011-2016)
  3.1.1 United States Alzheimer's Disease Drug Sales and Growth Rate (2011-2016)
  3.1.2 United States Alzheimer's Disease Drug Revenue and Growth Rate (2011-2016)
  3.1.3 United States Alzheimer's Disease Drug Sales Price Trend (2011-2016)
3.2 United States Alzheimer's Disease Drug Sales and Market Share by Manufacturers
3.3 United States Alzheimer's Disease Drug Sales and Market Share by Type
3.4 United States Alzheimer's Disease Drug Sales and Market Share by Application

4 CHINA ALZHEIMER'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Alzheimer's Disease Drug Sales and Value (2011-2016)
  4.1.1 China Alzheimer's Disease Drug Sales and Growth Rate (2011-2016)
  4.1.2 China Alzheimer's Disease Drug Revenue and Growth Rate (2011-2016)
  4.1.3 China Alzheimer's Disease Drug Sales Price Trend (2011-2016)
4.2 China Alzheimer's Disease Drug Sales and Market Share by Manufacturers
4.3 China Alzheimer's Disease Drug Sales and Market Share by Type
4.4 China Alzheimer's Disease Drug Sales and Market Share by Application

5 EUROPE ALZHEIMER'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Alzheimer's Disease Drug Sales and Value (2011-2016)
  5.1.1 Europe Alzheimer's Disease Drug Sales and Growth Rate (2011-2016)
  5.1.2 Europe Alzheimer's Disease Drug Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Alzheimer's Disease Drug Sales Price Trend (2011-2016)
5.2 Europe Alzheimer's Disease Drug Sales and Market Share by Manufacturers
5.3 Europe Alzheimer's Disease Drug Sales and Market Share by Type
5.4 Europe Alzheimer's Disease Drug Sales and Market Share by Application

6 JAPAN ALZHEIMER'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Alzheimer's Disease Drug Sales and Value (2011-2016)
  6.1.1 Japan Alzheimer's Disease Drug Sales and Growth Rate (2011-2016)
  6.1.2 Japan Alzheimer's Disease Drug Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Alzheimer's Disease Drug Sales Price Trend (2011-2016)
6.2 Japan Alzheimer's Disease Drug Sales and Market Share by Manufacturers
6.3 Japan Alzheimer's Disease Drug Sales and Market Share by Type
6.4 Japan Alzheimer's Disease Drug Sales and Market Share by Application

7 GLOBAL ALZHEIMER'S DISEASE DRUG MANUFACTURERS ANALYSIS

7.1 Eisai
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Alzheimer's Disease Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Eisai Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Pfizer
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 104 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Pfizer Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Novartis
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 124 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Shire
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Nov Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Shire Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Janssen
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Janssen Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Forest Laboratories
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Forest Laboratories Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 H. Lundbeck
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 H. Lundbeck Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Merz
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Merz Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Daiichi Sankyo
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview

8 ALZHEIMER'S DISEASE DRUG MAUFACTURING COST ANALYSIS

8.1 Alzheimer's Disease Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Alzheimer's Disease Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Alzheimer's Disease Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Alzheimer's Disease Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ALZHEIMER'S DISEASE DRUG MARKET FORECAST (2016-2021)

12.1 Global Alzheimer's Disease Drug Sales, Revenue Forecast (2016-2021)
12.2 Global Alzheimer's Disease Drug Sales Forecast by Regions (2016-2021)
12.3 Global Alzheimer's Disease Drug Sales Forecast by Type (2016-2021)
12.4 Global Alzheimer's Disease Drug Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Alzheimer's Disease Drug
Table Classification of Alzheimer's Disease Drug
Figure Global Sales Market Share of Alzheimer's Disease Drug by Type in 2015
Figure Centrally acting AChE inhibintors Picture
Figure NMDA antagonists Picture
Table Applications of Alzheimer's Disease Drug
Figure Global Sales Market Share of Alzheimer's Disease Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Alzheimer's Disease Drug Revenue and Growth Rate (2011-2021)
Figure China Alzheimer's Disease Drug Revenue and Growth Rate (2011-2021)
Figure Europe Alzheimer's Disease Drug Revenue and Growth Rate (2011-2021)
Figure Japan Alzheimer's Disease Drug Revenue and Growth Rate (2011-2021)
Figure Global Alzheimer's Disease Drug Sales and Growth Rate (2011-2021)
Figure Global Alzheimer's Disease Drug Revenue and Growth Rate (2011-2021)
Table Global Alzheimer's Disease Drug Sales of Key Manufacturers (2011-2016)
Table Global Alzheimer's Disease Drug Sales Share by Manufacturers (2011-2016)
Figure 2015 Alzheimer's Disease Drug Sales Share by Manufacturers
Figure 2016 Alzheimer's Disease Drug Sales Share by Manufacturers
Table Global Alzheimer's Disease Drug Revenue by Manufacturers (2011-2016)
Table Global Alzheimer's Disease Drug Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Alzheimer's Disease Drug Revenue Share by Manufacturers
Table 2016 Global Alzheimer's Disease Drug Revenue Share by Manufacturers
Table Global Alzheimer's Disease Drug Sales and Market Share by Type (2011-2016)
Table Global Alzheimer's Disease Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Alzheimer's Disease Drug by Type (2011-2016)
Figure Global Alzheimer's Disease Drug Sales Growth Rate by Type (2011-2016)
Table Global Alzheimer's Disease Drug Revenue and Market Share by Type (2011-2016)
Table Global Alzheimer's Disease Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Alzheimer's Disease Drug by Type (2011-2016)
Figure Global Alzheimer's Disease Drug Revenue Growth Rate by Type (2011-2016)
Table Global Alzheimer's Disease Drug Sales and Market Share by Regions (2011-2016)
Table Global Alzheimer's Disease Drug Sales Share by Regions (2011-2016)
Figure Sales Market Share of Alzheimer's Disease Drug by Regions (2011-2016)
Figure Global Alzheimer's Disease Drug Sales Growth Rate by Regions (2011-2016)
Table Global Alzheimer's Disease Drug Revenue and Market Share by Regions (2011-2016)
Table Global Alzheimer's Disease Drug Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Alzheimer's Disease Drug by Regions (2011-2016)
Figure Global Alzheimer's Disease Drug Revenue Growth Rate by Regions (2011-2016)
Table Global Alzheimer's Disease Drug Sales and Market Share by Application (2011-2016)
Table Global Alzheimer's Disease Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Alzheimer's Disease Drug by Application (2011-2016)
Figure Global Alzheimer's Disease Drug Sales Growth Rate by Application (2011-2016)
Figure United States Alzheimer's Disease Drug Sales and Growth Rate (2011-2016)
Figure United States Alzheimer's Disease Drug Revenue and Growth Rate (2011-2016)
Figure United States Alzheimer's Disease Drug Sales Price Trend (2011-2016)
Table United States Alzheimer's Disease Drug Sales by Manufacturers (2011-2016)
Table United States Alzheimer's Disease Drug Market Share by Manufacturers (2011-2016)
Table United States Alzheimer's Disease Drug Sales by Type (2011-2016)
Table United States Alzheimer's Disease Drug Market Share by Type (2011-2016)
Table United States Alzheimer's Disease Drug Sales by Application (2011-2016)
Table United States Alzheimer's Disease Drug Market Share by Application (2011-2016)
Figure China Alzheimer's Disease Drug Sales and Growth Rate (2011-2016)
Figure China Alzheimer's Disease Drug Revenue and Growth Rate (2011-2016)
Figure China Alzheimer's Disease Drug Sales Price Trend (2011-2016)
Table China Alzheimer's Disease Drug Sales by Manufacturers (2011-2016)
Table China Alzheimer's Disease Drug Market Share by Manufacturers (2011-2016)
Table China Alzheimer's Disease Drug Sales by Type (2011-2016)
Table China Alzheimer's Disease Drug Market Share by Type (2011-2016)
Table China Alzheimer's Disease Drug Sales by Application (2011-2016)
Table China Alzheimer's Disease Drug Market Share by Application (2011-2016)
Figure Europe Alzheimer's Disease Drug Sales and Growth Rate (2011-2016)
Figure Europe Alzheimer's Disease Drug Revenue and Growth Rate (2011-2016)
Figure Europe Alzheimer's Disease Drug Sales Price Trend (2011-2016)
Table Europe Alzheimer's Disease Drug Sales by Manufacturers (2011-2016)
Table Europe Alzheimer's Disease Drug Market Share by Manufacturers (2011-2016)
Table Europe Alzheimer's Disease Drug Sales by Type (2011-2016)
Table Europe Alzheimer's Disease Drug Market Share by Type (2011-2016)
Table Europe Alzheimer's Disease Drug Sales by Application (2011-2016)
Table Europe Alzheimer's Disease Drug Market Share by Application (2011-2016)
Figure Japan Alzheimer's Disease Drug Sales and Growth Rate (2011-2016)
Figure Japan Alzheimer's Disease Drug Revenue and Growth Rate (2011-2016)
Figure Japan Alzheimer's Disease Drug Sales Price Trend (2011-2016)
Table Japan Alzheimer's Disease Drug Sales by Manufacturers (2011-2016)
Table Japan Alzheimer's Disease Drug Market Share by Manufacturers (2011-2016)
Table Japan Alzheimer's Disease Drug Sales by Type (2011-2016)
Table Japan Alzheimer's Disease Drug Market Share by Type (2011-2016)
Table Japan Alzheimer's Disease Drug Sales by Application (2011-2016)
Table Japan Alzheimer's Disease Drug Market Share by Application (2011-2016)
Table Eisai Basic Information List
Table Eisai Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eisai Alzheimer's Disease Drug Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Alzheimer's Disease Drug Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Alzheimer's Disease Drug Global Market Share (2011-2016)
Table Shire Basic Information List
Table Shire Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Shire Alzheimer's Disease Drug Global Market Share (2011-2016)
Table Janssen Basic Information List
Table Janssen Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Janssen Alzheimer's Disease Drug Global Market Share (2011-2016)
Table Forest Laboratories Basic Information List
Table Forest Laboratories Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Forest Laboratories Alzheimer's Disease Drug Global Market Share (2011-2016)
Table H. Lundbeck Basic Information List
Table H. Lundbeck Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure H. Lundbeck Alzheimer's Disease Drug Global Market Share (2011-2016)
Table Merz Basic Information List
Table Merz Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merz Alzheimer's Disease Drug Global Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Daiichi Sankyo Alzheimer's Disease Drug Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimer's Disease Drug
Figure Manufacturing Process Analysis of Alzheimer's Disease Drug
Figure Alzheimer's Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Alzheimer's Disease Drug Major Manufacturers in 2015
Table Major Buyers of Alzheimer's Disease Drug
Table Distributors/Traders List
Figure Global Alzheimer's Disease Drug Sales and Growth Rate Forecast (2016-2021)
Figure Global Alzheimer's Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Alzheimer's Disease Drug Sales Forecast by Regions (2016-2021)
Table Global Alzheimer's Disease Drug Sales Forecast by Type (2016-2021)
Table Global Alzheimer's Disease Drug Sales Forecast by Application (2016-2021)